IL33 and heart failure: sST2 acts as a “decoy receptor” that, when released in response to mechanical stress, can inhibit the cardioprotective effects of the IL-33/ST2L signaling pathway.[3,6] In recent years, due to extensive research on sST2, its potential in the diagnosis of heart failure (HF) has become increasingly promising.